Skip to content

Prospective Cohort Study on Reperfusion Therapy for Acute Ischemic Stroke in Young Adults

Prospective Cohort Study on Reperfusion Therapy for Acute Ischemic Stroke in Young Adults

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117413
Enrollment
Unknown
Registered
2026-01-23
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

Sponsors

The Second Affiliated Hospital of the Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-50 years; 2.Preliminarily diagnosed with acute ischemic stroke based on clinical symptoms or imaging examinations; 3.The patient or their family members have signed a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.Intracranial hemorrhage confirmed by head CT or MRI; 2.Pregnant or lactating women; 3.End-stage of any disease resulting in an expected survival of <6 months; 4.Expected inability to complete follow-up; 5.Intracranial space-occupying lesions;

Design outcomes

Primary

MeasureTime frame
90 days favorable outcomes (%);Symptomatic intracranial hemorrhage (SICH) within 48 hours;

Secondary

MeasureTime frame
Distiburion of 1-year mRS Score;Proportion of patients with 1-year mRS 0-2;Proportion of patients with 15-year mRS 0-3;Proportion of patients with 10-year mRS 0-2;Proportion of patients with 5-year mRS 0-3;Proportion of patients with 20-year mRS 0-2;Distiburion of 15-year mRS Score;All-cause mortality at 90 days;Distiburion of 5-year mRS Score;Proportion of patients with 1-year mRS 0-3;Distiburion of 90-day mRS Score;Distiburion of 5-year mRS Score;Proportion of patients with 90-day mRS 0-3;Incidence of non-intracranial bleeding complications;Proportion of patients with 5-year mRS 0-2;Asymptomatic intracranial hemorrhage within 48 hours;Change in NIHSS score at 5-7 days post-treatment (If the time of discharge is earlier than 5-7 days, it is the time of discharge);Proportion of patients with 3-year mRS 0-3;Proportion of patients with 3-year mRS 0-2;Proportion of patients with 20-year mRS 0-3;Proportion of patients with 90-day mRS 0-4;Proportion of patients with 15-year mRS 0-2;90-day EQ-5D utility index score;Proportion of patients with 10-year mRS 0-3;Distiburion of 20-year mRS Score;Distiburion of 3-year mRS Score;

Countries

China

Contacts

Public ContactWenjie Zi

The Second Affiliated Hospital of the Army Medical University

ziwenjie@126.com+86 18523033816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026